SpicyIP
  • Log in

  • Home|
  • About Us|
  • Resources|
  • Internship|
  • Fellowship|
  • Contact

De-Coding Indian Intellectual Property Law

Follow us on Facebook Linkedin Twitter Google Plus Facebook

Menu

Skip to content
  • Latest
  • Copyright
  • Patent
  • Trademark
  • Others
    • Design
    • Geographical Indication
    • Plant Variety Protection
    • Biological Diversity
    • Traditional Knowledge
    • Innovation
    • Competition Law
    • Data Exclusivity
    • Drug Regulation
    • Privacy
    • Comparative Advertising
    • View All

NATCO Pharma Ltd. v. Shamnad Basheer

 

 

LIST OF DOCUMENTS

S.NO DATE

PARTICULAR(S)

1. 31.07.12 An article titled Patent “Perception”: A Contemtous Natco? published by Prof. Shamnad Basheer
2. 02.08.12 An article titled Breaking News: Natco Admits to Bad Faith and BMS attempts Patent Linkage! published by Prof. Shamnad Basheer
3. 13.08.12 NATCO Pharma Ltd filed a suit bearing CS (OS) 2475/12 against Prof. Shamnad Basheer seeking permanent injunction and damages for publishing defamatory articles against them
4. 18.09.12 Prof. Shamnad Basheer filed a Written Statement in CS (OS) 2475/12 
5. 12.12.12 Prof. Shamnad Basheer filed an Application bearing I.A. 22948/12 under Order VII Rule 11  seeking rejection of plaint for lack of cause of action
6. 12.12.12 Prof. Shamnad Basheer filed an Application bearing I.A. 23367/12 under Order VII Rule 10  seeking return of plaint for lack of territorial jurisdiction
7. 17.12.12 NATCO Pharma Ltd. filed replication to the Written Statement
8. 13.03.13 NATCO Pharma Ltd. filed a reply to I.A. 22948/12
9. 13.03.13 NATCO Pharma Ltd. filed a reply to I.A. 23367/12
 10. 21.11.14  Prof. Basheer letter to Mr. Anand Grover (Senior Advocate)

 

Library

  • IP BooksIP Books
  • All ResourcesAll Resources
  • IP Books - Open AccessIP Books – Open Access
  • Prof. (Dr.) Shamnad Basheer - Publications & Public Interest InterventionsProf. (Dr.) Shamnad Basheer – Publications & Public Interest Interventions
  • Ten Most Read Posts on SpicyIP in 2021Ten Most Read Posts on SpicyIP in 2021

Popular Posts

  • The Supreme Court’s Unsettling Attempt at Settling the Debate on Section 63 of the Copyright ActThe Supreme Court’s Unsettling Attempt at Settling the Debate on Section 63 of the Copyright Act
  • Announcing the 3rd Shamnad Basheer Essay Competition on Intellectual Property LawAnnouncing the 3rd Shamnad Basheer Essay Competition on Intellectual Property Law
  • Supreme Court’s S. 63 Copyright Decision: Sub Silentio and Limited Value?Supreme Court’s S. 63 Copyright Decision: Sub Silentio and Limited Value?
  • Trademarks and the Metaverse: Imaginary Rights or Real Wrongs?Trademarks and the Metaverse: Imaginary Rights or Real Wrongs?
  • MakeMyTrip vs Booking.com - Looking at the Delhi High Court Injunction on Usage of AdwordsMakeMyTrip vs Booking.com – Looking at the Delhi High Court Injunction on Usage of Adwords
  • A Look Back at India’s Top IP Developments of 2021A Look Back at India’s Top IP Developments of 2021
  • TRIPS Waiver: Is There Anything To Gain?TRIPS Waiver: Is There Anything To Gain?
  • Delhi High Court on 'Specified Value' of IP suits under Commercial Courts ActDelhi High Court on ‘Specified Value’ of IP suits under Commercial Courts Act
  • Of cosmetics, insolvency and trademarksOf cosmetics, insolvency and trademarks
  • Roof Afza v. Dil Afza: Finding Meaning in Trademark ProtectionRoof Afza v. Dil Afza: Finding Meaning in Trademark Protection

Topics

Biological Diversity Comparative Advertising Competition Law Copyright Courses & Workshops COVID-19 Data Exclusivity Design Drug Regulation Event Geographical Indication Innovation Opportunities Others Overlaps in IP Patent Plant Variety Protection Privacy Publication Sponsored Trademark Trade Secret Traditional Knowledge Uncategorized

Opportunities

  • Call for Submissions
  • Courses & Workshops
  • Essay Competitions
  • Fellowships & Scholarships
  • Job & Research Opportunities
  • Moot Court Competitions
  • Patent Drafting & Other Competitions
  • Webinars, Conferences & Other Events

Latest Comments

  • Shobhit { Mathews, on your point (i), the point is not over-valuation or under-valuation anymore, but correct valuation. If a brand owner 'correctly values' its IP, for perhaps 98% of... }
  • Mathews P. George { Thanks for the comments. i) It is not clear as to how this judgment will lead to over-valuation and flooding of cases in the high court. The more... }
  • Priya Sharma { I wasn't aware that one protects the design of the jewellery by copyrighting it. I think this will really make it possible for one to understand the importance... }
  • Akeo Blockchain Development { Hi Adarsh, Thanks for the information, very insightful post with clarity. Keep-up the good work }
  • Tom Bale { Thank you so much for the post you do and also I like your post. Now a days trade mark registration is on demand as people need this... }

Latest Opportunities

  • Call for Applications: Research Positions at Centre for Communication Governance (CCG) at NLU, Delhi [Apply by June 20] (June 11, 2022)
  • [Sponsored] Call for Applications: Associate Positions at Wadhwa Law Chambers, New Delhi (May 10, 2022)
  • [Sponsored] LexisNexis to Celebrate World IP Day with Daily Webinars (April 22, 2022)
  • Online Course/Workshop on Access to Medicines TRIPS and Patents [March 10 – April 8] (February 28, 2022)
  • NLUJ-CIPS Inter College IP Research Essay Writing Competition 2022 [Submit by March 10] (February 24, 2022)
  • [Sponsored] Short Course on ‘Pharmaceuticals and IP’ by British Institute of International and Comparative Law [March 4 – May 13] (February 7, 2022)
  • Call for Papers: NLU Jodhpur’s Journal of Intellectual Property Studies Vol. 5, Issue 2 [Submit by March 27] (February 7, 2022)
  • Online Course for Patent Agent Exam Preparation [February 5] (January 23, 2022)

Latest IP & COVID-19 Posts

  • Breaking: 12th WTO Ministerial Conference concludes with a Draft Decision on TRIPS (waiver?) (June 17, 2022)
  • Strong Statement by India at the 12th WTO Ministerial Conference (June 15, 2022)
  • TRIPS Waiver: Is There Anything To Gain? (June 10, 2022)
  • The Quad discussion group’s compromise falls short of a comprehensive TRIPS waiver (March 17, 2022)
  • High-Level Dialogue—TRIPS Waiver: Challenges & Opportunities? [September 13] (September 10, 2021)
  • Sun Pharma v. Cipla: Madras HC Rejects COVID as an Excuse for Passing Off (August 23, 2021)
  • Pandemic Push: Royalty-Based Business Model for Better Downstream Revenue for Musicians (July 14, 2021)
  • After Natco’s Withdrawal, Bajaj Healthcare files for Compulsory License to Manufacture Baricitinib (July 7, 2021)
  • Copyright Ownership in State Board Textbooks: Impediments to Accessibility (July 1, 2021)
  • Panel Discussion on ‘Pharma Corporations Demand Indemnity in Lieu of mRNA Vaccine Supply in India: Legal and Ethical Issues’ [June 23] (June 22, 2021)


  • Home |
  • About Us |
  • Archives |
  • Contact |
  • Terms & Conditions|
  • Site maintained by Anant Shrivastava